Industry

Artificial Intelligence-enabled Drug Discovery Competitive Analysis Report 2022: A Benchmarking System to Spark Companies to Action – Innovation that Fuels New Deal Flow and Growth Pipelines – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Artificial Intelligence-enabled Drug Discovery, 2022: Frost Radar Report” report has been added to ResearchAndMarkets.com’s offering. This report presents competitive profiles on each of the companies based on their strengths, opportunities, and a small discussion on their positioning. The report finds that the impact of AI on the entire pharma value chain can more … [Read more…]

Silence Therapeutics to Present at Jefferies Healthcare Conference

LONDON–(BUSINESS WIRE)–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that the Company will present at the Jefferies Healthcare Conference on Thursday, June 9th at 10:00 a.m. … [Read more…]

NanoString to Unveil New Platforms and Showcase Spatial Biology Research at 2022 Advances in Genome Biology and Technology (AGBT) General Meeting

Live webcast of Spatial Multiomic Symposium on Monday, June 6, from noon to 4 pm EDT Data from twenty scientific studies highlight the use of NanoString’s spatial biology platforms SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced plans to commercially unveil the CosMx™ … [Read more…]

Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases

Clinical-stage program UPB-101 targets the TSLP receptor, a cytokine receptor positioned upstream in the inflammatory cascade with the potential to impact multiple diseases, including asthma Pipeline growth strategy includes pursuing UPB-101 in multiple diseases and acquiring additional drug candidates Aaron Deykin, MD, appointed as Chief Medical Officer and Head of Research and Development WALTHAM, Mass.–(BUSINESS … [Read more…]

Global Non-Alcoholic Steatohepatitis Market Forecast to 2028 – Includes Performance Analyses of Leading Players Intercept Pharmaceuticals and Galmed Pharmaceuticals – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Non-Alcoholic Steatohepatitis Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel” report has been added to ResearchAndMarkets.com’s offering. The global non-alcoholic steatohepatitis (NASH) market is projected to reach US$ 24,266.81 million by 2028 from US$ 1,631.92 million in 2021; it is expected to grow at … [Read more…]

Global Kidney Cancer Market Forecast to 2028 – Abbvie, Bayer Pharma, Merck & Co, GlaxoSmithKline, and Pfizer Are Dominating the Industry – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Kidney Cancer Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global kidney cancer market is anticipated to grow at a substantial CAGR of 6.2% during the forecast period. As per the American Cancer Society, kidney cancer is among the 10 most common cancers in both men and women. Overall, the … [Read more…]

Global Clinical Trial Imaging Market Research Report 2022-2030 – Major Players are Developing Their CTI Services for Oncology, Neurology, and Musculoskeletal Applications – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Imaging Market Size, Share & Trends Analysis Report by Services (Clinical Trial Design and Consultation Services, Reading and Analytical Services), by End Use, by Application, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global clinical trial imaging market is expected to reach USD 1.97 billion … [Read more…]

BGI Releases 1st Panoramic Atlases of Life

SHENZHEN, China–(BUSINESS WIRE)–International scientists led by China’s BGI•Research released the world’s first panoramic spatial atlases of life on May 4, examining the cellular dynamics of organisms at different developmental stages and providing potentially significant new information for disease treatment, development and aging, and an improved understanding of biological evolution. In a series of studies published … [Read more…]

3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial

– AuriNovo™ an investigational, 3D-bioprinted implant was created using a proprietary process leveraging the patient’s own tissue to generate an implantable ear – – Phase 1/2a clinical trial enrolling patients with microtia, a rare congenital disorder where reconstruction options are limited – – AuriNovo™ granted Orphan Drug and Rare Pediatric Disease Designations by the U.S. … [Read more…]

German Mittelstand Leaders Skilfully Navigate Global Issues, Supply Chain Challenges and Ongoing Labour Shortages, Second Annual J.P. Morgan Survey Finds

Mittelstand companies face inevitable uncertainty, business challenges and rising geopolitical tensions head-on in the year ahead FRANKFURT, Germany–(BUSINESS WIRE)–Nearly all (95%) German Mittelstand leaders expect business repercussions from the war in Ukraine for at least six months, up 14% from March, citing higher energy prices (50%), commodity prices (47%) and inflation (38%) as the top … [Read more…]